Wendell Wierenga
Chairman chez CRINETICS PHARMACEUTICALS, INC.
Fortune : 6 M $ au 31/03/2024
Profil
Wendell D.
Wierenga is currently serving as the Chairman at Crinetics Pharmaceuticals, Inc. since 2015.
He is also an Independent Director at Cytokinetics, Inc. since 2011 and an Independent Director at Dermata Therapeutics, Inc. since 2016.
In his former positions, Dr. Wierenga served as the Chief Executive Officer at Syrrx, Inc. from 2000 to 2003.
He held the position of Executive Director-Discovery Research at Pharmacia & Upjohn, Inc. He also served as the Executive Director-Discovery Research at The Upjohn Co. from 1974 to 1990.
Dr. Wierenga was an Independent Director at Onyx Pharmaceuticals, Inc. from 1996 to 2013.
He served as an Independent Director at Apricus Biosciences, Inc. from 2014 to 2019.
Additionally, he held the position of Director at Aspira Women's Health, Inc., Concert Pharmaceuticals, Inc., Patara Pharma LLC, and SRI International.
Dr. Wierenga was an Independent Director at XenoPort, Inc. from 2000 to 2016.
He served as an Independent Director at OCERA Therapeutics LLC from 2013 to 2017 and at Anacor Pharmaceuticals LLC from 2014 to 2016.
He was the Vice President-Medtech Ventures at Warner-Lambert Co. from 1992 to 2000.
Dr. Wierenga also served as the Executive Vice President-Research & Development at Neurocrine Biosciences, Inc. from 2003 to 2006, at Santarus, Inc. from 2011 to 2014, and at Ambit Biosciences Corp.
from 2007 to 2011.
He held the position of Senior Vice President-Research at Parke-Davis Pharmaceutical Research, Inc. from 1990 to 2000.
He was also the Senior VP-Worldwide Pharmaceutical Sciences at Pfizer Inc. from 1990 to 2000.
Dr. Wierenga obtained a doctorate degree from Stanford University and an undergraduate degree from Hope College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/06/2023 | 105 846 ( 0,14% ) | 5 M $ | 31/03/2024 | |
| 29/02/2024 | 13 653 ( 0,01% ) | 957 212 $ | 31/03/2024 | |
| 20/03/2024 | 3 899 ( 0,06% ) | 1 602 $ | 31/03/2024 |
Postes actifs de Wendell Wierenga
| Sociétés | Poste | Début |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Director/Board Member | 09/02/2011 |
| CRINETICS PHARMACEUTICALS, INC. | Chairman | 01/10/2015 |
| DERMATA THERAPEUTICS, INC. | Director/Board Member | 20/09/2016 |
Anciens postes connus de Wendell Wierenga
| Sociétés | Poste | Fin |
|---|---|---|
Apricus Biosciences, Inc.
 Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | Director/Board Member | 24/01/2019 |
Patara Pharma LLC
 Patara Pharma LLC Pharmaceuticals: MajorHealth Technology Patara Pharma LLC provides biotechnology solutions. It develops biopharmaceutical therapy for the treatment of allergic and inflammatory diseases and conditions that affect orphan patient populations. The company was founded by William Gerhart, Pravin Soni and Ahmet Tutuncu in 2013 and is headquartered in San Diego, CA. | Director/Board Member | 01/11/2018 |
| OCERA THERAPEUTICS INC | Director/Board Member | 11/12/2017 |
| XENOPORT, INC. | Director/Board Member | 01/08/2016 |
| ANACOR PHARMACEUTICALS INC | Director/Board Member | 24/06/2016 |
Formation de Wendell Wierenga
| Stanford University | Doctorate Degree |
| Hope College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| PFIZER, INC. | Health Technology |
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| ASPIRA WOMEN'S HEALTH INC. | Health Technology |
| CYTOKINETICS, INCORPORATED | Health Technology |
| DERMATA THERAPEUTICS, INC. | Health Technology |
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 15 |
|---|---|
| Pharmacia & Upjohn, Inc. | Health Technology |
| The Upjohn Co. | Health Technology |
Warner-Lambert Co.
 Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ. | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | Health Technology |
Syrrx, Inc.
 Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | Health Technology |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Ambit Biosciences Corp. develops pharmaceutical drugs. It engages in discovery, development and commercialization of small-molecule kinase inhibitors for the treatment of cancer. The firm provides drug to treat unmet medical needs in oncology, autoimmune and inflammatory diseases. The company was founded on May 17, 2000 and is headquartered in San Diego, CA. | Health Technology |
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA. | Health Technology |
Patara Pharma LLC
Patara Pharma LLC Pharmaceuticals: MajorHealth Technology Patara Pharma LLC provides biotechnology solutions. It develops biopharmaceutical therapy for the treatment of allergic and inflammatory diseases and conditions that affect orphan patient populations. The company was founded by William Gerhart, Pravin Soni and Ahmet Tutuncu in 2013 and is headquartered in San Diego, CA. | Health Technology |
SRI International
 SRI International Miscellaneous Commercial ServicesCommercial Services SRI International provides contract research and development services. It is an independent, nonprofit research institute conducting client-sponsored research and development for government agencies, commercial businesses, foundations, and other organizations. The company was founded in 1946 and is headquartered in Menlo Park, CA. | Commercial Services |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
Ocera Therapeutics, Inc.
 Ocera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. manufactures pharmaceuticals products. The company was founded in 2004 and is headquartered in Hazelwood, MO. | Health Technology |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
| Parke-Davis Pharmaceutical Research, Inc. |
